Ardent Health (ARDT) EBIT (2023 - 2026)

Ardent Health's EBIT history runs 4 years deep, the most recent figure standing at -$90.6 million for Q1 2026.

• In Q1 2026, EBIT fell 60.09% year-over-year to -$90.6 million; the TTM figure through Mar 2026 stood at -$518.3 million (up 21.62% YoY), while the FY2025 annual figure was -$796.6 million, down 18.88% from the prior year.
• EBIT was -$90.6 million for Q1 2026 at Ardent Health, up from -$185.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $300.8 million in Q4 2023 to a low of -$511.0 million in Q4 2024.
• Historically, EBIT has averaged -$100.0 million across 4 years, with a median of -$69.7 million in 2023.
• The sharpest annual moves came in 2024 and 2025: EBIT plunged 269.89% in 2024, then jumped 71.89% in 2025.
• A 4-year view of EBIT shows it stood at $300.8 million in 2023, then slumped by 269.89% to -$511.0 million in 2024, then soared by 63.77% to -$185.2 million in 2025, then soared by 51.09% to -$90.6 million in 2026.
• The last three EBIT figures came in at -$90.6 million (Q1 2026), -$185.2 million (Q4 2025), and -$200.9 million (Q3 2025), per Business Quant data.